GlassScriptPhysician profile
David K Roberts
NPI 1780635607
$130,314.82
in general payments reported to CMS, 2019-2025
20 companies · $4,233 in 2025
The $4,233 reported for 2025 was more than what 81% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $73K · 2020: $23K · 2021: $4,596 · 2022: $14K · 2023: $7,192 · 2024: $3,948 · 2025: $4,233.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,437 · Travel and Lodging: $4,436 · Consulting Fee: $2,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,437.03 |
| Travel and Lodging | $4,435.86 |
| Consulting Fee | $2,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $61,353.68 | 2019-2020 | |
| Edwards Lifesciences Corporation | $38,569.74 | 2019-2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve, Edwards Sapien 3 Transcatheter Heart Valve (Thv), Evoque |
| Abbott Laboratories | $14,656.28 | 2019-2025 | Mitraclip, Triclip, Amplatzer Amulet |
| Medtronic, INC. | $12,249.82 | 2021-2025 | Harmony, Corevalve Evolut R, Onyx Frontier |
| Atricure, INC. | $671.12 | 2025 | Epi-Sense Guided Coagulation System With Visitrax |
| Teleflex LLC | $639.43 | 2025 | Manta, Guideliner |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $392.20 | 2021-2025 | Lifevest |
| Boston Scientific Corporation | $362.14 | 2019-2025 | Watchman Flx, Farapulse |
| Abiomed | $279.71 | 2021-2024 | Impella |
| Inari Medical, INC. | $260.42 | 2022 | |
| Philips North America LLC | $230.18 | 2024-2025 | Igt Devices Undivided, (P84) Igt Devices Systems, (Bq9) Coronary Ivus |
| Merit Medical Systems INC | $191.53 | 2025 | Embocath Plus Microcatheter |
| Recor Medical INC | $182.43 | 2024 | Paradise Renal Denervation System |
| E.R. Squibb & Sons, L.L.C. | $115.88 | 2024 | Camzyos |
| Heartflow, INC. | $78.02 | 2020-2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biosense Webster, INC. | $45.86 | 2024 | Carto 3 |
| W. L. Gore & Associates, INC. | $21.16 | 2022 | |
| Tempus Ai, INC | $15.22 | 2025 | Egg-Af |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$735,002.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Roberts listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.